Andrew Sharp
Latest contributions
Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use
22 May 2025 – From EuroPCR 2025
Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.
Updates on percutaneous treatment of pulmonary embolism
22 May 2025 – From EuroPCR 2025
Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.
A simple low profile solution to the pulmonary embolism problem: EKOS
21 May 2025 – From EuroPCR 2025
Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...
Innovative approaches to thrombus removal: redefining acute thromboembolic management in ACS
21 May 2025 – From EuroPCR 2025
Unlock cutting-edge strategies for thrombus removal in acute coronary syndrome (ACS) with this EuroPCR 2025 session. Understand the mechanisms behind microvascular obstruction and no-reflow phenomena, and why effective thrombus management is crucial. Review the latest clinical evidence, from the Cheetah study to the ongoing TACTIC randomised...
More on long-term responsiveness and effectiveness of renal denervation
21 May 2025 – From EuroPCR 2025
This session presents comprehensive data on the long-term responsiveness and effectiveness of renal denervation. Topics include outcomes in patients with chronic kidney disease, arterial stiffness correlations, safety profiles over nine years, and economic evaluations across European healthcare systems.
Key procedural factors in pulmonary embolism treatment with computer-assisted vacuum thrombectomy
20 May 2025 – From EuroPCR 2025
Watch this EuroPCR 2025 session on pulmonary embolism to explore the role of computer-assisted vacuum thrombectomy (CAVT) as an alternative to medical treatment in high-risk (massive) PE, supported by insights from the STRIKE PE study. Discover how CAVT rapidly and effectively offloads the right ventricle in intermediate-high-risk...
Ultrasound renal denervation is now guideline-recommended: how do I get started?
20 May 2025 – From EuroPCR 2025
Ultrasound renal denervation (uRDN) is now guideline-recommended—are you ready to bring it into practice? This EuroPCR 2025 session offers everything you need to get started: review key results from Sham-controlled and off-medication trials confirming the efficacy and safety of RDN; understand why both the ESC and...
Getting started with a renal denervation programme
20 May 2025 – From EuroPCR 2025
Begin your renal denervation program with this comprehensive session focusing on the importance of a multidisciplinary hypertension team, procedural techniques with current devices, and expected clinical outcomes across patient subgroups. Practical case examples illustrate effective team-based hypertension management and procedural execution.
Renal denervation: from guidelines to practice
17 Feb 2025
Discover what D. Milasinovic and A. Sharp shared on the practice of Renal denervation and learn more on the guidelines.
Heart to Heart Conversations podcasts – expert insights in interventional cardiology, anytime, anywhere
06 Feb 2025
Stay ahead in interventional cardiology with Heart-to-heart podcasts, the audio companion to our acclaimed webinar series.
Hypertension - the silver bullet of medicine
24 Sep 2024
In this Special Report, we describe how to safely integrate the latest additional guideline-recommended treatment option for some hypertensive patients - renal denervation.
Editorial: Hypertension and Renal Denervation
20 Sep 2024
Hypertension is the number one cause of years of life lost, and, perhaps more importantly, years of healthy living lost. It causes at least half of all heart attacks and strokes and is the major driver of heart failure.
Author
How to establish a renal denervation service
16 Oct 2024
Andrew Sharp and Valérie Duchatelle discuss the key elements of establishing a service for a Renal Denervation (RDN) programme. They cover team-building strategies, patient selection criteria, and the comprehensive patient pathway—detailing everything from lab work and in-depth investigations to lifestyle education and long-term follow-up.
The Essentials -...
How to perform safe and effective renal denervation
20 Sep 2024
Following the recent inclusion of renal denervation as an approved therapy in the 2023 European Society of Hypertension guidelines, Andrew Sharp and Felix Mahfoud discuss patient selection (for those with resistant hypertension or uncontrolled blood pressure), setting up best practices, the safe and appropriate use of contrast, choosing...
Thrombectomy for pulmonary embolism
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on catheter-directed therapy for pulmonary embolism. It includes presentations and discussions on an intelligent CT vacuum aspiration thrombectomy system, outcomes of catheter-directed therapy in intermediate-high and high-risk pulmonary embolism, and functional and quality of life outcomes in...
The turning point in hypertension care: Symplicity Spyral renal denervation in practice
15 May 2024 – From EuroPCR 2024
Explore this session to grasp the FDA-approved status of renal denervation, its safety and efficacy shown in numerous studies with lasting effects, and the importance of multidisciplinary discussions for successful indications. Consult also the session for updated recommendations on renal denervation in hypertension treatment guidelines, procedural safety...
Devices in pulmonary embolism - Why you should be interested!
15 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...
Revisiting thrombus aspiration in STEMI with continuous power aspiration system
15 May 2024 – From EuroPCR 2024
Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...
Renal denervation step by step: how to perform a safe and effective procedure
14 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of renal denervation, covering the essential aspects of patient selection, preprocedural assessment and imaging, the technical steps for performing safe and effective radiofrequency and ultrasound-based renal denervation, and the importance of post-procedural follow-up. The discussions aim to equip the audience...
Advancing percutaneous treatment of pulmonary embolism with computer-assisted vacuum thrombectomy
14 May 2024 – From EuroPCR 2024
Join this session to delve into innovations in computer-assisted vacuum thrombectomy for acute pulmonary embolism, leveraging real-life case scenarios to share practical experiences and discuss treatment strategies. Amidst the current surge in scientific research, ongoing trials like STORM PE and STRIKE PE are pivotal in shaping...
Renal denervation 2.0 - Ready for clinical use?
06 Dec 2023 – From GulfPCR-GIM 2023
Stay updated on the latest clinical evidence, guidelines, and technology related to renal denervation. Engage in discussions about the clinical experiences with ultrasound renal denervation (uRDN) and gain practical insights into selecting patients through real-world cases.
Is the invasive treatment of pulmonary embolism ready for prime time?
17 May 2023 – From EuroPCR 2023
In many parts of the world, pulmonary embolism is not a field traditionally reserved for cardiologists, but Catalin Toma and Andrew Sharp explain why they should be involved in its treatment.
As it is an RV failure problem that evolves from subclinical to frank shock, given that cardiologists...
Get ready – how to set up a successful renal denervation programme
18 May 2023 – From EuroPCR 2023
Delve into the essentials of renal denervation. Explore current evidence, program setup strategies, and building a multidisciplinary hypertension team.
Current trends in the invasive treatment of pulmonary embolism
18 May 2023 – From EuroPCR 2023
Embark on an exploration of the current trends in the invasive treatment of pulmonary embolism. Grasp the intricacies of establishing a catheter intervention service, navigate patient selection for advanced devices like catheter-directed thrombolysis and mechanical thrombectomy, and stay ahead by reviewing the latest clinical trials in...
Innovations in device-based treatment for hypertension
17 May 2023 – From EuroPCR 2023
Join this session to explore the latest innovations in device-based treatment for hypertension. Gain a comprehensive understanding of the evidence supporting the efficacy, durability, and safety of radiofrequency renal denervation, learn from renowned experts about the renal denervation procedure and receive valuable insights on patient selection...
Primary percutaneous pulmonary intervention (pPPI) of acute pulmonary embolism with computer-aided mechanical aspiration
16 May 2023 – From EuroPCR 2023
As there is a need for more awareness, training and data on primary percutaneous pulmonary intervention, watch this session to learn from shared pioneering experience!
Update on renal denervation
16 May 2023 – From EuroPCR 2023
Check out these slides if you want to refresh your memory regarding this session presenting an update on renal denervation.
From proof to practice - Treating hypertension with ultrasound renal denervation
16 May 2023 – From EuroPCR 2023
Renal denervation: what are the latest clinical evidences and benefits? How to select the good candidate? How to establish a dedicated centre? All the anwers to these questions and more in this video.
Comeback of renal denervation: The ESC Council on hypertension/EAPCI clinical consensus statement
16 May 2023 – From EuroPCR 2023
Ready to rejuvenate your memory of this session tackling on renal denervation? Investigate these slides and review the take home messages.
Interventions on Pulmonary Embolism: The Next Big Thing?
15 May 2023 – From PCR Innovators Day 2023